 |
CTSI Update: Announcement |
|
|
|
|
Congratulations and Best Wishes to Our Outstanding KL2 Scholars |
|
|
|
|
|
|
|
Modifiable Mediators of Maternal Adherence to Safe Sleep and Breastfeeding Among Black and Hispanic Mothers of Preterm Infants |
The goal of this KL2 is to use a well-established behavioral framework- the Theory of Planned Behavior - to investigate modifiable mediators of maternal adherence to safe sleep and breastfeeding among Black and Hispanic mothers of preterm infants to inform intervention development. |
|
|
|
|
|
|
|
Systems Modeling for Reducing Disparities in Youth Firearm Violence |
Dr. Jay’s KL2 project uses systems science methods, including group model building and computer simulation modeling, to identify promising leverage points and combination approaches. |
|
|
|
|
|
|
|
Resisting Racism: An Investigation
of the Effects of Racism on Health and Wellbeing, Protective Mechanisms, and
a Technology-based Intervention
|
Dr. Eschmann’s project will investigate the barriers to responding to racism and microaggressions, and use participatory design to develop a virtual-reality-based intervention to increase effective interpersonal responses to racial microaggressions. |
|
|
|
|
We are currently recruiting for two staff positions including a Senior Research Navigator (Tracking code 3481) and an Assistant Director, Program Evaluation (Tracking Code 0282). If you are interested in learning more about them, please go here
|
|
|
|
|
Training for Bench, Clinical, Biomedical, Translational and Population Health Researchers |
Are you planning to submit a Career Development Award? Have you assembled mentors and developed a Specific Aims page, but want to ensure that you submit the most competitive application possible? The Career Development Award Grant Writing Workshop, sponsored by the BU CTSI, is open to Faculty and accomplished Post-doctoral Students/Fellows who will be remaining at BUMC. More Details Here
|
The overarching goal of the BU CTSI Pilot Grant Program is to help investigators explore and solve major challenges in translational science, especially those that address the special health problems of our urban communities, by developing and deploying new tools, methods, and processes to expedite clinical and translational research and discovery. See Full RFA Here
|
|
|
|
|
New Funding Opportunities |
|
|
|
|
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
|
Notice of Special Interest: Alzheimer’s-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimer’s Disease
National Institute on Aging (NIA)
|
|
|
|
Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed)
Office of The Director, National Institutes of Health (OD)
|
Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide
National Institute of Allergy and Infectious Diseases (NIAID)
|
|
|
|
Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
National Human Genome Research Institute (NHGRI)
|
|
|
|
|
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
After the administration of a single dose of vaccine, the humoral response against SARS-CoV-2 in persons with a history of SARS-CoV-2 infection is greater than the response in previously uninfected participants who have received a second dose. Read More
|
|
|
|
|
Single-Shot COVID-19 Vaccine Produces Immune Response Against Variants
The researchers tested antibodies and immune cells from samples taken 57 days after vaccination. They tested activity against the original strain of SARS-Cov-2 as well as several variants. These included the alpha, beta, and gamma variants. Read More
|
|
|
|
|
Adjuvant Developed with NIH Funding Enhances Efficacy of India’s COVID-19 Vaccine
An adjuvant developed with funding from the NIH has contributed to the success of the highly efficacious COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and elsewhere. Read More
|
|
|
|
|
Telepractice Presents a Challenge
to Voice Therapy
Boston University researchers urge caution when evaluating voice disorders over teleconferencing platforms due to differences in acoustic measurements. Read More
|
|
|
|
|
NIH Data Challenge Seeks Innovative Methods for Identifying Complication Risks in First-Time Pregnancies
The NIH will award up to $400,000 to individuals or groups who design an effective method for analyzing a large data set of first-time pregnancies and identifying risk factors for adverse outcomes. Read More
|
|
|
|
|
Hematologic Malignancies
Jul. 17, 2021, 8 a.m. - 5 p.m.
This webcast offers oncologists who are involved in the care of patients with hematologic malignancies, the opportunity to interact with leading faculty, build their base of clinical knowledge, maintain awareness of controversies in the field. Read More
|
|
|
|
|
2022 Biomedical Data Science
Innovation Lab
Virtual Event: Oct. 1, 2021 -
In-Person Event: Jun. 13 - 17, 2022
iTHRIV is excited to announce this opportunity to participate in the next Biomedical Data Science Innovation Lab! Read More
|
|
|
|
|
The Funding Acknowledgement |
|
|
|
|
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.
|
|
|
|
|
|
|
|
|
